Skip to content

Study · Not a test of the peptide alone · 1996

2 results

Development of specific anti-thymosin beta 10 antipeptide antibodies for application in immunochemical techniques.

Leondiadis L, Livaniou E, Vassiliadou I, Ferderigos N, Ithakissios DS, Evangelatos GP

Peptides1 Jan 1996Cited by 6 (Europe PMC)

PMID8959741 (opens in a new tab)DOI10.1016/s0196-9781(96)00187-8 (opens in a new tab)PepBankPUB-08959741
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, the peptide was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking the peptide.

  1. 01LabNot a test of Thymosin alpha-1 aloneIn vitro (cell-free)Other

    Antisera raised against thymosin beta 10 fragments showed minimal cross-reactivity with synthetic thymosin alpha‑1 in binding tests.

    In plain wordsIn lab tests, antibodies made against thymosin beta 10 barely reacted with thymosin alpha‑1.

    Peptide
    Thymosin alpha-1
    Outcome
    No significant changeAntiserum cross-reactivity with thymosin alpha 1
    Study

    n: not reported in source

    Antisera binding assay with synthetic and natural peptides
    Outcome group
    Receptor activity and mechanism · Immune and inflammation

    Source sentences

    Summary
    showing minimal cross-reactivity with thymosin beta 4 isolated from bovine tissues or synthetic thymosin alpha 1

    In this study, Thymosin alpha-1 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin alpha-1.

  2. 02LabNot a test of Thymosin beta-4 (human) aloneIn vitro (cell-free)Activity measurement

    Antisera raised against thymosin beta 10 fragments showed minimal cross-reactivity with thymosin beta‑4 isolated from bovine tissues.

    In plain wordsIn lab tests, antibodies made against thymosin beta 10 bound thymosin beta‑4 only very little.

    Peptide
    Thymosin beta-4 (human)
    Outcome
    Not applicableAntiserum cross-reactivity
    Study

    n: not reported in source

    Outcome group
    Receptor activity and mechanism · Pharmacology

    Source sentences

    Summary
    showing minimal cross-reactivity with thymosin beta 4 isolated from bovine tissues or synthetic thymosin alpha 1.

    In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin beta-4 (human).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 4Current

    12 Oct 2026, 18:17 UTC

    Study data updated · source update from Europe PMC

  2. Version 3

    10 Oct 2026, 08:55 UTC

    Study results updated

  3. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  4. Version 1

    9 Oct 2026, 03:02 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.